Kate Skrable is an expert in the field of alliance management, specifically complex collaborations and international partnerships. She recently joined Pfizer as the Vice President of Strategic Partnerships. For more than 20 years, she was a member of Seagen with her last leadership role as the Vice President of Strategic Alliances. Prior to her time at Seagen, she spent close to 10 years at Genentech/Roche as a leader in alliance management, asset management, and bio-analytics. She also has held a number of roles at Valeant Pharmaceuticals, Connetics Corporation and Dow Pharmaceuticals. Kate is well-versed in mergers/acquisitions, licensing (both sell and buy-side), and strategic alliances. She holds an MBA from Santa Clara University and a Master of Science from the University of Arizona.